Key result
HCG stimulation testing confirms aberrant adrenal hormone regulation in pregnancy-induced Cushing syndrome with micronodular disease.
Why the study?
Pregnancy-induced Cushing syndrome is an extremely rare entity with significant maternal-fetal morbidity, and diagnosing primary pigmented nodular adrenocortical disease can be challenging without overt Cushingoid features and typical imaging.
HCG stimulation testing is useful in identifying aberrant adrenal activity in pregnancy-induced hypercortisolism, and surgery can restore endocrine function.
Answers are grounded in this paper and cite their sources.
HCG testing may aid rare pregnancy-induced Cushing cases; hypothesis-generating and should not change practice.
Introduction Pregnancy-induced Cushing syndrome (CS) is an extremely rare entity. Its recognition is crucial due to significant maternal-fetal morbidity. Among ACTH-independent causes, bilateral micronodular adrenal disease (Primary Pigmented Nodular Adrenocortical Disease-PPNAD) is usually associated with Carney complex (CNC) and PRKAR1A mutations. However, about 10%–20% of patients can also present without CNC features. Diagnosing PPNAD can be challenging in the absence of overt Cushingoid features and typical imaging findings. Clinical Case A 32-year-old woman was referred for the investigation of possible pregnancy-induced CS. She had the story of second-trimester miscarriage due to severe preeclampsia 10 months before admission. She described cushingoid physical features during pregnancy that vanished following fetal loss. She was nulliparous and her sister also reported to experience gestational CS with preterm deliveries. Several paternal female cousins had similar stories. She was normotensive on bisoprolol 10mg/day, and her physical examination reminded any sign of hypercortisolism. Pregnancy was excluded and hormonal evaluation at follicular phase of the menstrual cycle revealed; suppressed ACTH levels, <1.5pg/mL, baseline cortisol, 33.79mcg/dl, elevated 24-hour urinary free cortisol,195µg/day (4.3-176). Both 1 mg overnight and low-dose dexamethasone suppression tests exhibited no suppression, even paradoxical increase; 12.1mcg/dl and 15.2mcg/dl, respectively. Midnight serum cortisol was normal,7.1µg/dl. Tests were repeated the next menstrual period and were the same. They were compatible with ACTH independent Cushing’s syndrome in the absence of physical findings. HCG stimulation test was performed with 250mcg choriogonadotrophine alpha. Her cortisol was found to be responsive to HCG and diurnal rhythm was lost (Table 1). This supported the presence of aberrant adrenal hormone regulation. She exhibited no mucocutaneous pigmentation and cardiac myxomas. Thyroid and breast ultrasonographic examinations were normal. PRKAR1A genetic testing returned negative. Adrenal venous sampling was not performed due to almost symmetric gland involvement. She underwent right total and left subtotal adrenalectomy. Histopathology confirmed bilateral micronodular adrenal disease. (Figure 2). Postoperatively, her morning cortisol was 4.6 µg/dl. She was put on 5 mg prednisolone per day. She experienced reduction in blood pressure and 2.5 kg weight loss within weeks. Adrenal insufficiency wasn't observed. Fertility counseling was deferred due to recent surgeries. Conclusion This case illustrates the diagnostic complexity of pregnancy-induced hypercortisolism. HCG stimulation testing is useful in identifying aberrant adrenal activity. The absence of PRKAR1A mutation and classic pigmentation does not exclude PPNAD, further genetic analyses are required. Surgery can restore endocrine function and improve the course of following pregnancies.
No takes yet. Share an insight, caveat, or question.
Simsek et al. (2026) studied this question. HCG stimulation testing confirmed aberrant adrenal hormone regulation in a patient with pregnancy-induced Cushing syndrome and bilateral micronodular adrenal disease.
Synapse has enriched 10 related papers. Consider them for comparative context: